F
Fardous F. El-Senduny
Researcher at Mansoura University
Publications - 53
Citations - 920
Fardous F. El-Senduny is an academic researcher from Mansoura University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 11, co-authored 38 publications receiving 514 citations. Previous affiliations of Fardous F. El-Senduny include South Dakota State University & King Abdulaziz University.
Papers
More filters
Journal ArticleDOI
Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective
Mohammad Hosein Farzaei,Mahdi Zobeiri,Fatemeh Parvizi,Fardous F. El-Senduny,Ilias Marmouzi,Ericsson Coy-Barrera,Rozita Naseri,Seyed Mohammad Nabavi,Roja Rahimi,Mohammad Abdollahi +9 more
TL;DR: Electronic databases were extensively searched and results showed that curcumin exerts remarkable protective and therapeutic effects of oxidative associated liver diseases through various cellular and molecular mechanisms.
Journal ArticleDOI
On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective
Zeinab Nouri,Sajad Fakhri,Fardous F. El-Senduny,Nima Sanadgol,Ghada E Abd-ElGhani,Mohammad Hosein Farzaei,Jen-Tsung Chen +6 more
TL;DR: The neuroprotective effects of naringenin, as well as its related pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective, are described and the need to develop novel naringanin delivery systems is discussed to solve its widespread pharmacokinetic limitation.
Journal ArticleDOI
Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents.
Mohammad Shahidul Islam,Hussien Mansur Ghawas,Fardous F. El-Senduny,Abdullah Mohammed Al-Majid,Yaseen A.M.M. Elshaier,Farid A. Badria,Assem Barakat,Assem Barakat +7 more
TL;DR: Compound 4k proved to retain a high cytotoxic activity and selectivity against colon cancer cells HCT-116, hepatocellular carcinoma, and prostate cancer cells PC-3 in comparison to cisplatin, and ligand Efficiency and Ligand Lipophilic Efficiency were evaluated and revealed that compound 4k had acceptable value.
Journal ArticleDOI
Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B
Fardous F. El-Senduny,Fardous F. El-Senduny,Farid A. Badria,Ahmed M. El-Waseef,Subhash C. Chauhan,Fathi T. Halaweish +5 more
TL;DR: Cucurbitacin B is a promising chemosensitizer for the cisplatin-resistant ovarian cancer and shows cytotoxicity against the ovarian cancer cell lines, and pretreatment of A2780CP cells leads to a significant increase in the cytotoxic effect of cisPlatin.
Journal ArticleDOI
Substituted spirooxindole derivatives as potent anticancer agents through inhibition of phosphodiesterase 1
Assem Barakat,Assem Barakat,Mohammad Shahidul Islam,Hussien Mansur Ghawas,Abdullah Mohammed Al-Majid,Fardous F. El-Senduny,Farid A. Badria,Yaseen A.M.M. Elshaier,Hazem A. Ghabbour,Hazem A. Ghabbour +9 more
TL;DR: A one-pot three-component reaction via a [3 + 2] cycloaddition/ring contraction sequence of a dipolarophile (activated alkene) with in situ-generated azomethine ylide (1,3-dipoles) without the use of any catalyst provides efficient access to synthetically useful and biologically important spirooxindoles in high yield with high diastereoselectivity.